Journal
CHEMICAL COMMUNICATIONS
Volume 53, Issue 40, Pages 5523-5526Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7cc01946g
Keywords
-
Categories
Funding
- Spanish Ministry of Economy and Competitiveness [CTQ2015-64319-R, CTQ2014-52658-R]
- FEDER funds [CTQ2015-64319-R, CTQ2014-52658-R]
- Czech Science Foundation [17-09436S]
- COST [CM1105, CM1406]
- MetDrugs network [CTQ2015-70371-REDT]
- Fundacion Seneca-CARM [19020/FPI/13]
Ask authors/readers for more resources
A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminescent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
